These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 26996272)
1. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study. Serafino-Agrusa L; Scichilone N; Spatafora M; Battaglia S Pulm Pharmacol Ther; 2016 Apr; 37():89-94. PubMed ID: 26996272 [TBL] [Abstract][Full Text] [Related]
2. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD. Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799 [TBL] [Abstract][Full Text] [Related]
3. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions. Couillard S; Larivée P; Courteau J; Vanasse A Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201 [TBL] [Abstract][Full Text] [Related]
4. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization. Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252 [TBL] [Abstract][Full Text] [Related]
5. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD). Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850 [TBL] [Abstract][Full Text] [Related]
6. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD]. Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228 [No Abstract] [Full Text] [Related]
7. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink. Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236 [TBL] [Abstract][Full Text] [Related]
8. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD. Prins HJ; Duijkers R; Lutter R; Daniels JM; van der Valk P; Schoorl M; Kerstjens HA; van der Werf TS; Boersma WG Respir Med; 2017 Oct; 131():118-124. PubMed ID: 28947018 [TBL] [Abstract][Full Text] [Related]
9. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol. Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909 [TBL] [Abstract][Full Text] [Related]
10. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis. Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777 [TBL] [Abstract][Full Text] [Related]